OnKure Therapeutics, Inc. (OKUR) Stock Analysis

OnKure Therapeutics, Inc. (OKUR) is a publicly traded company in the HEALTHCARE sector. It trades at $4.22, carries a market capitalization of $169.66M. This page summarizes the public market data, fundamentals, and frequently asked questions for OKUR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.22
• Market Cap: $169.66M
• EPS: $-4.32
• 52-Week High: $5.38
• 52-Week Low: $1.91

About OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc. is an innovative biopharmaceutical firm dedicated to revolutionizing cancer treatment through the development of precision oncology therapies. Located in Boulder, Colorado, the company utilizes cutting-edge drug discovery platforms to target unmet needs in cancer care, showcasing a strong commitment to personalized medicine. With a diverse pipeline of targeted therapeutic candidates, OnKure is poised to make significant strides in enhancing patient outcomes and resha...

GNG Research Analysis

GNG Research scores OnKure Therapeutics, Inc. (OKUR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OKUR.

Frequently Asked Questions

Does OKUR pay dividends?

OnKure Therapeutics, Inc. (OKUR) does not currently pay a regular dividend.

What is OKUR's market cap?

OnKure Therapeutics, Inc. (OKUR) has a market capitalization of $169.66M with a current stock price of $4.22.